Status:
UNKNOWN
Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Patients
Lead Sponsor:
Heidelberg University
Conditions:
Aspergillosis
Immunosuppression
Eligibility:
All Genders
18+ years
Brief Summary
Although being a frequent and lethal complication in patients (pts) with hematologic malignancies, diagnosing invasive aspergillosis (IA) still remains a difficult issue as culture-based methods show ...
Eligibility Criteria
Inclusion
- Immunocompromised individuals with suspicion of harbouring an invasive fungal infection
- Definition by 2008 EORTC/MSG Criteria (de Pauw CID 2008)
Exclusion
- none
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01902030
Start Date
January 1 2014
End Date
December 1 2020
Last Update
April 20 2020
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Cologne University Hospital
Cologne, Germany, 50937
2
Duesseldorf University Hospital
Düsseldorf, Germany, 40225
3
Eschweiler General Hospital
Eschweiler, Germany, 52249
4
Frankfurt (Oder) General Hospital
Frankfurt (Oder), Germany, 15236